期刊文献+

抗糖尿病药致不良反应的文献分析 被引量:4

Literature Analysis of Adverse Drug Reaction Induced by Antidiabetic Agents
原文传递
导出
摘要 目的:探讨抗糖尿病药致不良反应发生的情况,为临床合理用药服务。方法:通过中国期刊全文数据库(CNKI)收集1998-2011年发表的抗糖尿病药致不良反应发生的相关文献,对不良反应发生的患者性别与年龄构成、发生时间分布、累及器官或系统、药品种类等进行汇总、分析。同时对糖尿病并发症相关药物的不良反应亦做了归纳与分析。结果:抗糖尿病药引发不良反应的年龄主要集中于51岁以上;发生时间主要集中于1d~2个月;累及器官或系统涉及全身各大系统,其中最常见的为胃肠道反应;严重不良反应主要发生于心血管系统、免疫系统、内分泌系统中,包括室性早搏、低血糖性昏迷、过敏性休克、全身剥脱性皮炎甚至死亡等。结论:糖尿病及其并发症治疗药物产生的不良反应是广泛的,有些甚至是严重的;广大临床医师及药师应对其进行密切的监测,积极推进抗糖尿病药临床合理使用。 OBJECTIVE: To investigate the adverse drug reaction (ADR) of antidiabetic agents, and to provide reference for rational drug use in the clinic. METHODS: Related literatures of ADR induced by antidiabetic agents were collected from CNKI database during 1998-2011. Patient’s gender and age, occurrence time, involved organs or system and drug varieties were summarized and analyzed. ADR of diabetes complication drugs were also summarized and analyzeds. RESULTS: ADR of antidiabetic agents mainly occurred in patients aged 51 years above and often appeared from 1 day to 2 months. Organs or systems involved in ADR were general body system. General ADR reactions wrer disturbances of the digestive tract. Serious ADR happened in the systems of cardiovascular, immunity and endocrine. ADR symptoms often included VPC, glycopenia coma, anaphylactic shock, exfoliative dermatitis, death and so on. CONCLUSION: ADRs induced by drugs for diabetes and complication are extensive and serious. Doctors and clinic pharmacists should monitor the ADR carefully for the advance of rational use of antidiabetic agents in the clinic.
出处 《中国药房》 CAS CSCD 2012年第46期4385-4387,共3页 China Pharmacy
关键词 糖尿病 用药安全 不良反应 文献分析 Diabetes mellitus Medication safety Adverse drug reaction Literature analysis
  • 相关文献

参考文献3

二级参考文献22

  • 1吴永贵,林辉,钱浩,赵珉,戴宏,郝丽,张伯科.灯盏花素与LY333531对糖尿病大鼠肾脏的保护作用[J].中华肾脏病杂志,2004,20(6):429-433. 被引量:39
  • 2李志坚,许乃贵,何柏林,李士梅.抵克力得及中药灯盏花素、藏红花在大鼠阳离子化牛血清白蛋白肾炎中的影响[J].中华肾脏病杂志,1996,12(6):363-365. 被引量:46
  • 3American Diabetes Association Position Statement:Diabetic neophropathy[J].Diabetes care,1998,21:s50.
  • 4El - Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clinical Gastroenterology and Hepatology 2006;4(3) :369 -380.
  • 5Adami HO, ChowWH, Nyren O, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J Nail Cancer Inst 1996;88 (20) : 1472 - 1477.
  • 6Larsson SC, Orsini N, Brismar K, et al. Diabetes mellitus and risk of bladder cancer: a meta -analysis. Diabetologia 2006 ;49 (12) :2819 -2823.
  • 7Mitri J, Castillo J, Pittas AG. Diabetes and risk of non - Hodgkin' s lymphoma: a meta - analysis of observational studies. Diabetes Care 2008 ;31 (12) :2391 - 2397.
  • 8Bonovas S, Filioussi K, Tsantes A. Diabetes mellitus and risk of prostate cancer: a meta - analysis. Diabetologia 2004; 47 (6) :1071 - 1078.
  • 9Vigneri P, Frasca F, Sciacca L, et al. Diabetes and cancer. Endocr Relat Cancer 2009;16(4) :1103 - 1123.
  • 10Lipscombe LL, Goodwin PJ, Zinman B, et al. The impact of diabetes on survival following breast cancer. Breast Cancer Res Treat 2008; 109(2) :389 -395.

共引文献11

同被引文献17

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部